Project/Contract NHS National Framework for Denosumab Injection

NHS EnglandcontractFind a TenderRef ocds-h6vhtk-05506aProcurement Act 2023SME suitablepending
View buyer

Estimated value

Awarded value

£52.8m

Awarded 29 Sept 2025

Suppliers

7

Lots

2

2 awarded

Published

02 Oct 2025

Description

Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026 Offer reference number: CM/TNS/25/5725 Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/TNS/25/5725/01 - Regional award for Denosumab Injection: NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months) SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months) MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months) LNW: (London) 01/01/2026 to 31/12/2026 (12 months) CM/TNS/25/5725/02 - National award for Denosumab Injection: 7NAT (National) 01/01/2026 to 31/12/2026 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Scope

Reference
C370255
Commercial tool
Standalone contract
Contract dates
01 Jan 2026 to 31 Dec 2026
Possible extension to 31 Dec 2028

Option or options to extend (at the discretion of the Authority) up to maximum of 24 months.

CPV classifications
33600000
Contract locations
North East England, United Kingdom
North West England, United Kingdom
Yorkshire and the Humber, United Kingdom
East Midlands, United Kingdom
West Midlands, United Kingdom
East of England, United Kingdom
London, United Kingdom
South East England, United Kingdom
South West England, United Kingdom
Particular suitability
Small and medium-sized enterprises (SME)

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
Price is not the only award criterionprice100.00%

Submission & procedure

Procedure
Open procedure

Award details· 2 awards

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£37.7m

Award date

29 Sept 2025

Contract start

01 Jan 2026

Contract end

31 Dec 2026

Lots · 2 total

Divisions of the contract. Each lot can be awarded separately.

View all →
LotTitleEst. valueStatus
1CM/TNS/25/5725/01 - Regional award for Denosumab Injection£36.0mcomplete
2CM/TNS/25/5725/02 - National award for Denosumab Injection£21.0mcomplete